Sierk Marbus

632 total citations
12 papers, 106 citations indexed

About

Sierk Marbus is a scholar working on Epidemiology, Emergency Medicine and Infectious Diseases. According to data from OpenAlex, Sierk Marbus has authored 12 papers receiving a total of 106 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 3 papers in Emergency Medicine and 2 papers in Infectious Diseases. Recurrent topics in Sierk Marbus's work include Influenza Virus Research Studies (11 papers), Respiratory viral infections research (7 papers) and Pneumonia and Respiratory Infections (4 papers). Sierk Marbus is often cited by papers focused on Influenza Virus Research Studies (11 papers), Respiratory viral infections research (7 papers) and Pneumonia and Respiratory Infections (4 papers). Sierk Marbus collaborates with scholars based in Netherlands, Romania and Portugal. Sierk Marbus's co-authors include Wim van der Hoek, Arianne B. van Gageldonk‐Lafeber, Jaap T. van Dissel, Geert H. Groeneveld, Jan Jelrik Oosterheert, Peter M. Schneeberger, Frederika Dijkstra, Gé Donker, Valentijn A. Schweitzer and Noor Hafizah Ismail and has published in prestigious journals such as Vaccine, Critical Care and International Journal of Antimicrobial Agents.

In The Last Decade

Sierk Marbus

12 papers receiving 104 citations

Peers

Sierk Marbus
Emily K. Johnson United States
Saumil Doshi United States
Alaina Stoute United States
Ben Waite New Zealand
Max W. Jacobs New Zealand
Sierk Marbus
Citations per year, relative to Sierk Marbus Sierk Marbus (= 1×) peers Andros Theo

Countries citing papers authored by Sierk Marbus

Since Specialization
Citations

This map shows the geographic impact of Sierk Marbus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sierk Marbus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sierk Marbus more than expected).

Fields of papers citing papers by Sierk Marbus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sierk Marbus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sierk Marbus. The network helps show where Sierk Marbus may publish in the future.

Co-authorship network of co-authors of Sierk Marbus

This figure shows the co-authorship network connecting the top 25 collaborators of Sierk Marbus. A scholar is included among the top collaborators of Sierk Marbus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sierk Marbus. Sierk Marbus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Adlhoch, Cornelia, Concepción Delgado‐Sanz, AnnaSara Carnahan, et al.. (2023). Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020. Eurosurveillance. 28(4). 5 indexed citations
2.
Marbus, Sierk, et al.. (2020). Costs of a clinical pathway with point‐of‐care testing during influenza epidemic in a Dutch hospital. Influenza and Other Respiratory Viruses. 15(2). 202–205. 4 indexed citations
3.
Marbus, Sierk, Valentijn A. Schweitzer, Geert H. Groeneveld, et al.. (2020). Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study. The European Journal of Health Economics. 21(5). 775–785. 20 indexed citations
4.
Groeneveld, Geert H., Sierk Marbus, Noor Hafizah Ismail, et al.. (2020). Effectiveness of oseltamivir in reduction of complications and 30-day mortality in severe seasonal influenza infection. International Journal of Antimicrobial Agents. 56(5). 106155–106155. 13 indexed citations
5.
Marbus, Sierk, Wim van der Hoek, Jaap T. van Dissel, & Arianne B. van Gageldonk‐Lafeber. (2020). Experience of establishing severe acute respiratory surveillance in the Netherlands: Evaluation and challenges. Public Health in Practice. 1. 100014–100014. 8 indexed citations
6.
Marbus, Sierk, et al.. (2019). Media Reports as a Source for Monitoring Impact of Influenza on Hospital Care. JMIR Public Health and Surveillance. 6(1). e14627–e14627. 3 indexed citations
7.
Asten, Liselotte van, Frederika Dijkstra, Gé Donker, et al.. (2019). Surveillance of influenza and other respiratory infections: winter 2018/2019. Annual report. Rivm (National Institute for Public Health and the Environment). 2 indexed citations
8.
Asten, Liselotte van, Angie Luna Pinzon, Dylan W. de Lange, et al.. (2018). Estimating severity of influenza epidemics from severe acute respiratory infections (SARI) in intensive care units. Critical Care. 22(1). 351–351. 12 indexed citations
9.
Adeoti, Adekunle Olatayo & Sierk Marbus. (2018). The European Respiratory Society course on acute respiratory pandemics: how to plan for and manage them. ERJ Open Research. 4(1). 156–2017. 4 indexed citations
10.
Dijkstra, Frederika, et al.. (2018). Annual report Surveillance of influenza and other respiratory infections: Winter 2017/2018. Rivm (National Institute for Public Health and the Environment). 7 indexed citations
11.
Rondy, Marc, Odile Launay, Jesús Castilla, et al.. (2017). Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza. Vaccine. 35(34). 4298–4306. 20 indexed citations
12.
Asten, Liselotte van, Frederika Dijkstra, Arianne B. van Gageldonk‐Lafeber, et al.. (2015). Annual report Surveillance of influenza and other respiratory infections in the Netherlands: winter 2014/2015.. Data Archiving and Networked Services (DANS). 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026